JYNT Stock Recent News

– New App Brings Convenient Features to Patients – SCOTTSDALE, Ariz. , July 1, 2025 /PRNewswire/ -- Today, The Joint Corp. (NASDAQ: JYNT), the nation's largest franchisor of chiropractic care through The Joint Chiropractic ® network, announces the launch of its new mobile app, now available for download in the Apple App Store and Google Play.

Bridgend Asset Management Limited Renamed to Willis Mitsui & Co. Asset Management Limited Bridgend Asset Management Limited Renamed to Willis Mitsui & Co. Asset Management Limited

Agreement with Beijing Tongchuang Technology Development Co., Ltd. strengthens regional momentum through purchase, service, and licensing of flagship products LAS VEGAS, June 30, 2025 (GLOBE NEWSWIRE) -- Richtech Robotics Inc. (Nasdaq: RR) (“Richtech Robotics” or the “Company”), a Nevada-based provider of AI-driven service robots, today announced the signing of a multi-million-dollar sales agreement with Beijing Tongchuang Technology Development Co., Ltd.

Vancouver, British Columbia--(Newsfile Corp. - June 27, 2025) - Kenorland Minerals Ltd. (TSXV: KLD) (OTCQX: KLDCF) (FSE: 3WQ0) ("Kenorland" or the "Company") announces that Newmont Corporation ("Newmont") has delivered a notice to terminate the joint venture agreement in respect of the Healy project (the "Project") in Alaska.

The Donald Project, a JV between Energy Fuels and Astron Corporation, is considered one of the World's best near-term sources of rare earth minerals, which Energy Fuels intends to process into "light", "mid" and "heavy" rare earth oxides at its White Mesa Mill in Utah. DENVER , June 25, 2025 /PRNewswire/ - Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) ("Energy Fuels" or the "Company"), a leading U.S. producer of uranium, rare earth elements ("REEs"), and other critical minerals, is pleased to announce that the Government of Victoria, Australia has approved the Work Plan for the construction and operation of the Donald Rare Earth and Mineral Sand Project (the "Donald Project") located in the Wimmera region of Victoria.

Technology Co-Developed by the U.S. Department of Veterans Affairs and Emory University NEW YORK, June 25, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery systems, today announced that it has entered into a non-binding letter of intent to form a strategic 50:50 joint venture with Hoth Therapeutics, Inc. (Nasdaq: HOTH) to develop and commercialize a potential treatment for obesity and metabolic disease based on technology Hoth has exclusively licensed from the U.S. Department of Veterans Affairs (VA) that was co-developed by the VA and Emory University. The novel therapeutic platform centers on glial cell line-derived neurotrophic factor (GDNF), a VA-invented biologic with demonstrated anti-obesity effects and metabolic regulation in preclinical models.

- The Joint to Deploy Capital and Enhance Profitability Profile by Reducing Regional Developer Count - - Largest Franchisee Signs Binding Asset Purchase Agreement to Acquire 31 Corporate Clinics, Which Will Increase Its Ownership to 96 Clinics, and Committed to Opening 10 More Clinics -

CHARLOTTE, N.C. & CHICAGO--(BUSINESS WIRE)--Today, Krispy Kreme, Inc. (NASDAQ: DNUT) and McDonald's USA announced that, after careful consideration, the companies have jointly decided to end their partnership, effective July 2, 2025. “We were excited and pleased to partner with Krispy Kreme,” said Alyssa Buetikofer, McDonald's USA's Chief Marketing and Customer Experience Officer. “We had strong collaboration with Krispy Kreme and they delivered a great, high-quality product for us, and while t.

SAN FRANCISCO--(BUSINESS WIRE)--Xcell Biosciences (Xcellbio), a San Francisco-based instrumentation company focused on cell and gene therapy applications, today announced a strategic collaboration with Thermo Fisher Scientific Inc., the world leader in serving science, to advance research in regulatory T cells (Tregs) and tumor-infiltrating lymphocytes (TILs). While significant progress has been made in the cell therapy space leveraging Chimeric Antigen Receptor T (CAR T) cells, this collaborat.

SCOTTSDALE, Ariz.--(BUSINESS WIRE)-- #HomeMeansEverything--loanDepot, Inc. (NYSE: LDI) and Onx Homes, announced that their new joint venture, ONX X+ Mortgage, is now serving homebuyers in Florida and Texas. The partnership pairs Onx Homes' innovative approach to homebuilding with loanDepot's best-in-class lending platform to deliver a seamless, tech-forward mortgage experience for new construction homebuyers. “With our joint venture now serving customers in Florida and Texas, we're thrilled to continue our work trans.